全球呼吸道疾病:梅波利祖马布同时改善了严重CRSwNP和喘的结果
J Mullol1, V Backer2, J Constantinidis3
1Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic Barcelona, IDIBAPS, CIBERES, Barcelona, Catalonia, Spain.
Rhinology
|December 11, 2024
概括
梅波利祖马布改善了慢性鼻炎与鼻息肉 (CRSwNP) 和喘患者的症状. 这项研究验证了mepolizumab作为全球呼吸道疾病的治疗方法,改善生活质量和呼吸控制.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 临床试验 临床试验
背景情况:
- 具有鼻息肉的慢性鼻炎 (CRSwNP) 经常与喘和非类固醇抗炎药物加剧的呼吸道疾病 (N-ERD) 一起发生.
- 这种共同发生代表了一种被称为"全球呼吸道疾病"或"统一呼吸道疾病"的严重表型,需要综合治疗方法.
- 共享的免疫失调是这些相互关联的呼吸条件的基础.
研究的目的:
- 评估mepolizumab - - 一种抗列金-5单克隆抗体 - - 在同时治疗CRSwNP和喘方面的疗效.
- 评估mepolizumab对全球呼吸道疾病患者的生活质量,鼻症状和喘控制的复合终点的影响.
- 为验证mepolizumab作为全球呼吸道疾病复杂管理的治疗选择.
主要方法:
- 对第三期随机,双盲,安慰剂控制,多中心SYNAPSE研究 (NCT03085797) 的后期分析.
- 患者接受了梅波利祖马布或安慰剂.
- 使用评估生活质量,鼻症状和喘控制的结合终点来衡量疗效.
主要成果:
- 与安慰剂相比,梅波利祖马布在联合终点上显示出显著的改善.
- 抗干白素-5疗法有效地同时解决了CRSwNP和喘症状.
- 接受梅波利祖马布治疗的患者经历了更好的生活质量和更好的呼吸系统症状控制.
结论:
- 梅波利祖马布是CRSwNP和同时存在的喘患者的有效治疗方法,解决了全球呼吸道疾病的概念.
- 这项研究支持mepolizumab在改善统一呼吸道疾病患者综合治疗结果方面的作用.
- 向介质蛋白-5为管理全球呼吸道疾病等复杂呼吸道疾病提供了一个有希望的治疗策略.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178
Antiasthma Drugs: Leukotriene Modifiers
243
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
243
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
218
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
218
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
232
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
232


